Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,677.8
24.8 (0.94%)

 

  • STI Straits Times Index
    2,677.8
    24.8 (0.94%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.6
    18.9 (1.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,223.1
    850.0 (3.35%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,313.6
    160.8 (5.10%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,713.9
    407.4 (1.83%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,995.2
    21.5 (0.43%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 765.0M
  • Value: 472.0M
  • Rise: 221
  • Fall: 60
  • Unch: 527

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Singapore-eDev0.120+0.005
Medtecs Intl0.585+0.085
Rex Intl0.184+0.004
LionGold0.002-
Synagie0.197+0.006
Yoma Strategic0.320+0.005
MDR0.001-
AnAn Intl0.070+0.006
KOP0.068+0.007
Spackman0.009-0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

HARTA HARTALEGA HOLDINGS BHD
Quotes 15 Minutes Delayed. Updated at 06 Jul 2020 12:29
Last (MYR): 16.940 Change: +0.940 High: 17.020 Remarks:
Change (%): +5.88 Low: 16.020
Open 16.020 Yesterday's Close 16.000
Buy Price 16.940 Sell Price 16.960
Buy Volume ('00) 168 Sell Volume ('00) 117
Cumulative Volume ('00) 105,640 Cumulative Value 177,002,736
Click to show Stock Prices chart

Latest News

View All News

Key Statistics

EPS (MYR) a 0.12833 Trailing EPS (MYR) e 0.12833 NAV (MYR) b 0.7500
PE a 132.003 Trailing PE f 132.004 Price / NAV b 22.5867
Dividend (MYR) d - Cash In Hand (MYR) g 0.0900 Issued & Paid-up Shares c 3,388,006,000
Dividend Yield (%) d - Price / Cash In Hand g 188.222 Treasury Shares h -
Beta - 75 Daysi 0.937 R-Squared - 75 Days(%)i 10.86 Market Cap (M) 57,392.822
Beta - 500 Daysi 0.758 R-Squared - 500 Days (%)i 8.70 Enterprise Value (M) 57,369.952
Piotroski F Score 5 Exchange Code 5168 Par Value ( $ ) n.a.
52 Weeks Volatility (%) 47.46 6-Month VWAP 8.496 Free Float (%) 37.9
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Medical Specialties
Index Components BM HEALTH CARE / FBM EMAS / FBM EMAS SHARIAH / FBM HIJRAH SHARIAH / FBM KLCI / FBM TOP 100
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 Jun 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Jun 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference HARTA Bursa 57,392.822 132.003 132.004 22.5867 -
Industry HEALTH CARE EQUIPMENT & SERVICES Bursa 1,702.067 114.898 85.856 14.6572 0.208
Medical Specialties Bursa 29,087.455 126.457 94.194 16.2549 0.165
Index BM HEALTH CARE Bursa 10,888.710 100.800 101.164 5.2967 0.416
FBM EMAS Bursa 5,126.879 20.642 24.200 1.3317 3.174
FBM EMAS SHARIAH Bursa 4,787.237 33.638 40.951 1.6792 2.319
FBM HIJRAH SHARIAH Bursa 18,481.871 27.732 37.165 1.8330 2.472
FBM KLCI Bursa 33,494.487 18.990 21.696 1.7126 3.245
FBM TOP 100 Bursa 13,036.703 19.909 22.865 1.5115 3.102
Local Peer TOPGLOV Bursa 55,443.549 152.039 85.407 16.4298 0.346
Local Peer SUPERMX Bursa 13,456.617 109.305 95.419 10.8327 -
Local Peer LKL Bursa 270.144 - - - -
Global Peer ABBOTT LABORATORIES NYSE 163,141.035 44.501 46.098 5.3988 1.426
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 144,508.621 39.099 39.386 5.0600 0.210
Global Peer DANAHER CORP NYSE 127,293.757 51.147 46.508 4.3216 0.372
Global Peer MEDTRONIC PLC NYSE 124,955.508 26.092 26.092 2.4628 2.318
Global Peer BECTON DICKINSON & CO NYSE 69,460.859 64.197 76.331 3.3157 1.199
Global Peer STRYKER CORP NYSE 68,945.862 33.099 31.860 5.2570 1.160
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,694.417 49.079 48.831 7.9578 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 50,548.467 10.755 11.791 3.6619 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,375.588 44.331 43.463 5.7638 0.970
Global Peer EDWARDS LIFESCIENCES CORP NYSE 42,874.552 40.954 38.702 10.9904 -
Other Global Peers KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), IDEXX LABORATORIES INC (NASDAQ), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), STERIS PLC (NYSE), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), Top Glove (SGX), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), WEIGAO GROUP (HKEx), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), COCHLEAR LTD (ASX), MICROPORT (HKEx), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), GLOBUS MED INC (NYSE), KANGJI MEDICAL (HKEx), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), AK MEDICAL (HKEx), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), PEIJIA-B (HKEx), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), INARI MEDICAL INC (NASDAQ), EBOS GROUP (ASX), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), KDL MEDICAL (HKEx), AXONICS MODULATION TECHNLOGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), SILK ROAD MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), LIFETECH SCI (HKEx), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CIRC (HKEx), ACCELERATE DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ZYNEX INC (NASDAQ), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), YESTAR HEALTH (HKEx), CORMEDIX INC (NYSE American), CYTOSORBENTS CORP (NASDAQ), VIEWRAY INC (NASDAQ), PW MEDTECH (HKEx), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), MEDICAL DEVELOPMENT INTL (ASX), ALPHATEC HLDGS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), STEREOTAXIS INC (NYSE American), GOLDEN MEDITECH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ALPHA PRO TECH (NYSE American), MISONIX INC (NASDAQ), INVACARE CORP (NYSE), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), SIENTRA INC (NASDAQ), Medtecs Intl (SGX), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), UG Healthcare (SGX), APYX MEDICAL CORPORATION (NASDAQ), MODERN DENTAL (HKEx), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), VINCENT MED (HKEx), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), CELSION CORPORATION (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), YUNNAN ENERGY (HKEx), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), Biolidics (SGX), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), DIMERIX LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), ONCOCYTE CORP (NYSE American), COMPUMEDICS (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESONANCE HEALTH LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), KELFRED (HKEx), ZOSANO PHARMA CORP (NASDAQ), RESPIRI LTD (ASX), MOTUS GI HOLDINGS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IMMUCELL CORP (NASDAQ), NEOVASC INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEURONETICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), Yunnan Energy (SGX), MICRO-X LTD (ASX), ELECTROCORE INC (NASDAQ), LBT INNOVATIONS LTD (ASX), IRIDEX CORP (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), METALICITY LIMITED (ASX), NEUROTROPE INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), LIFE HEALTHCARE (HKEx), MYOS RENS TECHNOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), AETHLON MEDICAL INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), AVINGER INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), ENDOLOGIX INC (NASDAQ), CYANOTECH CORP (NASDAQ), OPTISCAN IMAGING (ASX), DIGIRAD CORP (NASDAQ), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), Annica (SGX), ADHERIUM LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ANALYTICA (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DORSAVI LTD (ASX), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), OBALON THERAPEUTICS INC (NASDAQ), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+5.000
+41.88 %
10 Days -+4.860
+40.23 %
20 Days 0.021+4.740
+39.02 %
Medium Term Return 3 Months 0.021+10.040
+145.81 %
6 Months 0.039+11.540
+214.43 %
1 Year 0.076+11.720
+225.98 %
Long Term Return 2 Years 0.161+11.140
+194.84 %
3 Years 0.281+13.515
+402.80 %
5 Years 0.461+14.740
+690.95 %
Annualised Return Annualised --
+51.23 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 4.800 - 16.000 Change From 1 Year Low +12.140 % Change From 1 Year Low (%) +252.92
Change From 1 Year High +0.940 % Change From 1 Year High (%) +5.88
2 Years Range 4.520 - 16.000 Change From 2 Years Low +12.420 % Change From 2 Years Low (%) +274.78
Change From 2 Years High +0.940 % Change From 2 Years High (%) +5.88
5 Years Range 1.905 - 16.000 Change From 5 Years Low +15.035 % Change From 5 Years Low (%) +789.24
Change From 5 Years High +0.940 % Change From 5 Years High (%) +5.88
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Established in 1988, Hartalega began with this VISION to produce gloves that protect what matters most, LIFE.



From a humble beginning of a One-Line-Operation, Hartalega has experienced tremendous growth and evolved into a sizeable company of 43 Production Lines, with a capacity to produce over 8 billion gloves annually.



Since inception, every phase of our operation has been dedicated to a Tradition of Excellence.


IPO Performance

Listing Date 17 Apr 2008 Full Subscription Rate (x) -
No of Placement Shares (M) - No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (MYR) 1.800 First Day Close (MYR) 1.910 First Week Close (MYR) 1.790
Current vs IPO Price (%) +841.11 First Day Gain (%) +6.11 First Week Gain (%) -0.56

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Mar 2019 Part 1(2.69 MB)
Part 2(1.14 MB)
Annual Report 2018 Mar 2018 Part 1(2.47 MB)
Part 2(2.71 MB)
Part 3(0.68 MB)
Annual Report 2017 Mar 2017
Annual Report 2016 Mar 2016 Part 1(2.89 MB)
Part 2(2.90 MB)
Annual Report 2015 Mar 2015 Part 1(2.99 MB)
Annual Report 2014 Mar 2014 Part 1(2.06 MB)
Annual Report 2013 Mar 2013 Part 1(2.10 MB)
Annual Report 2012 Mar 2012 Part 1(2.28 MB)
Part 2(2.23 MB)
Annual Report 2011 Mar 2011 Part 1(0.12 MB)
Part 2(3.08 MB)
Part 3(2.85 MB)
Annual Report 2010 Mar 2010 Part 1(2.72 MB)
Annual Report 2009 Mar 2009 Part 1(2.24 MB)
Part 2(0.04 MB)
Annual Report 2008 Mar 2008 Part 1(0.85 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
03 Jul 2020 15.240 16.000 14.820 16.000 12,743,400 15.3864
02 Jul 2020 14.740 15.600 14.600 15.000 16,681,200 15.0665
01 Jul 2020 13.060 15.000 13.040 14.780 17,048,500 14.0775
30 Jun 2020 12.560 13.160 12.500 13.000 11,056,800 12.9420
29 Jun 2020 11.940 12.500 11.700 12.500 6,244,000 12.1933
26 Jun 2020 12.100 12.160 11.840 11.940 6,470,000 11.9617
25 Jun 2020 11.980 12.100 11.920 12.100 5,938,100 12.0342
24 Jun 2020 11.980 12.120 11.920 12.100 5,984,700 12.0441
23 Jun 2020 12.000 12.100 11.840 12.000 4,589,500 11.9413
22 Jun 2020 12.060 12.280 11.900 11.980 8,872,400 12.0695
19 Jun 2020 11.300 12.180 11.220 12.080 13,310,700 11.8408
18 Jun 2020 12.000 12.020 11.200 11.500 11,453,400 11.5121
17 Jun 2020 12.160 12.260 11.820 11.940 5,891,700 11.9600
16 Jun 2020 12.020 12.360 11.820 12.040 10,995,100 12.0011
15 Jun 2020 12.800 12.880 11.680 11.680 20,203,900 12.0774
12 Jun 2020 11.700 12.520 11.520 12.520 13,129,700 12.2933
11 Jun 2020 12.720 13.120 12.440 12.440 14,173,300 12.7722
10 Jun 2020 12.900 12.980 12.500 12.500 9,075,900 12.6402
09 Jun 2020 12.600 13.500 12.380 12.520 17,668,000 12.7354
05 Jun 2020 12.080 12.360 11.900 12.200 12,450,900 12.1515
04 Jun 2020 10.720 11.820 10.600 11.780 16,284,800 11.5898
03 Jun 2020 12.480 12.740 9.400 11.220 25,688,300 11.0196
Summary
Current 2 Weeks
(22 Jun 2020 to 03 Jul 2020)
12.060 16.000 11.700 16.000 95,628,600 -
Previous 2 Weeks
(05 Jun 2020 to 19 Jun 2020)
12.080 16.000 11.700 12.080 128,352,600 -
4 Weeks from
(04 May 2020 to 04 Jun 2020)
7.580 16.000 7.310 11.780 284,416,100 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.